Download FREE Report Sample
Download Free sampleAnalgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief.
Injectable Pain Medication Market contains market size and forecasts of Injectable Pain Medication in Global, including the following market information:
Global Injectable Pain Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Injectable Pain Medication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Pain Medication include GlaxoSmithKline, Merck, Pfizer, Novartis, Sanofi, Bayer, Johson & Johson, Boehringer Ingelheim and Sun Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injectable Pain Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Pain Medication Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Injectable Pain Medication Market Segment Percentages, by Type, 2021 (%)
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Central Analgesics
Global Injectable Pain Medication Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Injectable Pain Medication Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinics
Recovery Center
Global Injectable Pain Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Injectable Pain Medication Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Pain Medication revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Injectable Pain Medication revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck
Pfizer
Novartis
Sanofi
Bayer
Johson & Johson
Boehringer Ingelheim
Sun Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
